Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 1-50 of 238 result(s).
CYDY CytoDyn Inc
05/07/2025 10:35:48 AM
Thanks. You're the best. I forgot a (11)
CYDY CytoDyn Inc
05/06/2025 11:44:03 PM
Not sure if they ever disclosed rec (5)
CYDY CytoDyn Inc
05/05/2025 2:28:23 PM
CCR5 bound by leronlimab would have (5)
CYDY CytoDyn Inc
08/20/2024 3:41:55 PM
Agree, there is lots of jibberish o (8)
CYDY CytoDyn Inc
08/13/2024 4:52:30 PM
Agree with you that the primary end (15)
CYDY CytoDyn Inc
08/13/2024 1:33:54 PM
Q: Are we hoping to improve upon th (11)
CYDY CytoDyn Inc
06/04/2024 12:08:14 PM
No, VIR is developing broadly neutr (7)
CYDY CytoDyn Inc
05/16/2024 3:07:46 PM
Ha, good questions and observations (1)
CYDY CytoDyn Inc
05/16/2024 2:34:44 PM
I wondered the same (new priority o (4)
CYDY CytoDyn Inc
05/16/2024 1:39:46 PM
Good to see some progress on trial (4)
CYDY CytoDyn Inc
05/15/2023 3:02:38 PM
It's nice that pubmed links to the (2)
CYDY CytoDyn Inc
05/15/2023 2:09:25 PM
Except the mice with disabled CCR5 (5)
CYDY CytoDyn Inc
12/19/2022 4:10:16 PM
Stiff person's syndrome neurodiagno (5)
CYDY CytoDyn Inc
12/14/2022 11:14:13 PM
Lipid nanoparticles encapsulation l (4)
CYDY CytoDyn Inc
12/14/2022 4:19:42 PM
Only problem with AAV transgene pro (9)
CYDY CytoDyn Inc
10/28/2022 10:36:32 PM
HIV patients with NASH is an area o
CYDY CytoDyn Inc
08/08/2022 10:59:26 PM
Hahaha, a rhetorical question. For (1)
CYDY CytoDyn Inc
08/03/2022 9:06:33 AM
Sorry .. can't edit on phone .. thi
CYDY CytoDyn Inc
08/03/2022 9:00:54 AM
I think the Sasha grant was a Cente
CYDY CytoDyn Inc
07/27/2022 6:25:59 PM
Nice writeup. In the news recently (7)
CYDY CytoDyn Inc
07/11/2022 12:25:58 PM
This will be in monkeys, like Sacha (6)
CYDY CytoDyn Inc
07/05/2022 5:37:52 PM
Yes I think they have already had s (1)
CYDY CytoDyn Inc
07/05/2022 8:08:07 AM
Unfortunately, AAV is not currently (4)
CYDY CytoDyn Inc
07/05/2022 12:44:26 AM
No, only one daughter cell would ge (3)
CYDY CytoDyn Inc
05/13/2022 2:37:48 PM
FDA is another corrupt failed burea (3)
CYDY CytoDyn Inc
04/01/2022 1:57:30 PM
The reason for the clinical hold wa (2)
CYDY CytoDyn Inc
03/31/2022 9:08:19 PM
Nice .. 7 years of safe monotherapy (3)
CYDY CytoDyn Inc
02/28/2022 4:27:24 PM
Well, the analysis probably is wron (6)
CYDY CytoDyn Inc
02/28/2022 2:32:57 PM
Great question, and it's too bad th (8)
CYDY CytoDyn Inc
02/17/2022 5:46:12 PM
Dark matter is not repulsive. Not s (1)
CYDY CytoDyn Inc
02/17/2022 5:27:41 PM
For the record, Rathke admitted to (1)
CYDY CytoDyn Inc
02/17/2022 4:49:29 PM
No, take a closer look at it. Take (3)
CYDY CytoDyn Inc
02/17/2022 3:53:32 PM
Forever is a very long time for a s (4)
CYDY CytoDyn Inc
02/17/2022 3:42:20 PM
Another review article from that si (5)
CYDY CytoDyn Inc
02/16/2022 1:01:19 PM
There are some long lived memory T- (1)
CYDY CytoDyn Inc
02/15/2022 2:38:37 PM
Patterson recently posted prelimina (7)
CYDY CytoDyn Inc
02/14/2022 12:00:41 PM
Nice review of chemokine signaling (6)
CYDY CytoDyn Inc
02/02/2022 12:37:39 PM
Lots of options/possibilities for f
CYDY CytoDyn Inc
02/02/2022 12:08:16 PM
I wonder if this financing is someh
CYDY CytoDyn Inc
01/31/2022 4:40:40 PM
They stopped recruiting for all the (8)
CYDY CytoDyn Inc
01/28/2022 2:11:50 PM
Which part do you take as speculati (1)
CYDY CytoDyn Inc
01/28/2022 1:46:28 PM
The 11/27/22 8-K says (b) On Januar (3)
CYDY CytoDyn Inc
01/28/2022 12:43:33 PM
Thanks for pulling this out. One ve (1)
CYDY CytoDyn Inc
01/26/2022 9:43:41 PM
Bingo: Its possible that the cytoki (4)
CYDY CytoDyn Inc
01/25/2022 11:33:51 AM
Several other therapies that work . (2)
CYDY CytoDyn Inc
01/20/2022 11:24:12 AM
Canceled CC, waiting for updates on (5)
CYDY CytoDyn Inc
01/15/2022 1:57:59 PM
Cash bond is because Amarex claims (3)
CYDY CytoDyn Inc
01/12/2022 1:15:58 PM
Nice article. Agree that Omicron in (7)
CYDY CytoDyn Inc
01/11/2022 11:31:08 AM
Unfortunately, 10-Q page 35 says: I (4)
CYDY CytoDyn Inc
01/10/2022 11:40:15 AM
Regnum is now run by Anne Kirby, fo (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Strategic Merger: Vigil Neuroscience and Sanofi Join Forces
  • Greenhawk Resources Moves Forward with Greenland Properties Venture
  • SK hynix Unveils Advanced UFS 4.1 Memory Solution for AI
  • Sanofi Expands Neurology Pipeline with Vigil Neuroscience Merger
  • Raymond James Financial Announces Latest Dividend Payments
  • Shocking Abuse Statistics from the Archdiocese Exposed
  • Oyster Enterprises II Acquisition Corp's IPO Raises $220 Million
  • Capitalize on Bitcoin's Rise: Daily Earnings with PAIRMiner
  • Trading 212 Reaches A$50 Billion in Client Assets Milestone
  • Outstanding Growth and Financial Performance by LexinFintech
  • NOVONIX Celebrates Key Tariff Decision Impacting Graphite Industry
  • Investors of Bakkt Holdings, Inc. Urged to Take Action Now
  • Cracker Barrel Welcomes Steve Bramlage to Its Board of Directors
  • BlackRock’s May Distributions for iShares ETFs Unveiled
  • Frankenmuth Insurance Welcomes New Chief Legal Officer
  • Zenas BioPharma Investors: An Update on Class Action Lawsuit
  • OMRON Healthcare Enhances Blood Pressure Monitors with AI
  • TAT Technologies Signs Major MRO Deal with Leading Cargo Carrier
  • Connecting with Investors: Oroco Resource Announces Townhall
  • Solar Alliance Energy Inc. Moves Toward Sustainable Profitability
  • Investigation Commences into Paramount Group's CEO Misconduct
  • Investigation into XP Inc. Potential Securities Issues Alerting Investors
  • HealthEquity, Inc. Investors: Key Insights on Class Action Risks
  • Exploring Passive Income: The Advantages of PBK Miner
  • APA Corporation Declares Exciting New Cash Dividend for Shareholders
  • Prospera Energy Enhances Production with New Financing Initiatives
  • Seaboard Corporation Introduces Major Share Buyback Initiative
  • Actinium Pharmaceuticals Faces Class Action: Know Your Rights
  • New Found Gold Unveils Promising Drill Results from Queensway Project
  • Weyerhaeuser Transitions Ownership of Princeton Lumber Mill
  • BankFirst Capital Corporation Launches New Share Buyback Initiative
  • Tucows Appoints Diverse Board Members to Drive Innovation Forward
  • Elbit Systems Launches Major Public Offering of Shares
  • NowVertical Group Reports Impressive Q1 Growth and Future Plans
  • OceanaGold's Commitment to Sustainability Shines in 2024 Report
  • Innovative Migraine Solutions Emerge: A New Chapter for Patients
  • Express Car Wash Colorado Successfully Sold to Club Car Wash
  • Investors' Chance to Navigate NAPCO Securities Class Action
  • Zions Bancorporation's Upcoming Participation in Financial Conference
  • Discover the Newly Transformed Sukai Bar & Lounge Experience
  • SCHMID Group's Progress Amid Market Changes and Innovations
  • Senseonics Revels in Successful Offering and Strategic Placement
  • Poker Royalty Welcomes Jesse Lonis: The Rising Poker Star
  • Clairvest Strengthens Environmental Services Investment Strategy
  • Helium Evolution Receives Strong Support from Shareholders
  • LGI Homes Unveils Five New Communities in Winston-Salem Area
  • Voting Results Announced by BULGOLD for Shareholder Meeting
  • CEMATRIX Secures $5.7 Million in New Construction Contracts
  • Premier Health of America Inc. Delivers 2025 Q2 Financial Update
  • Vaxart's Annual Meeting Update: Key Dates and Voting Information
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site